Cosmos Health extends LOI to acquire Cana Labs; renegotiates payment terms

Cosmos Health Inc.

Updated binding LOI to acquire Greek pharma company Cana Laboratories; effective until May 31, 2023.
Acquisition price renegotiated with improved payment terms; no dollar amount disclosed.
Cana owns a 54,000 sq ft GMP-certified production facility in Athens, Greece.
Cana has partnerships with AstraZeneca, Merck, Medtronic, Nestle, and others.
CEO says acquisition would vertically integrate manufacturing and expand product portfolio.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.